OpenVSafe by OpenVAERS
Search V-safe

MN2-31439-87219

2 vaccinations 2 coded responses 13 check-ins 2 free-text entries 4 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
910 / CA
Registered
2020-12-20
Relationship
Self

Timeline

  1. 2020-12-20
    Registered in v-safe
  2. 2020-12-20
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-20
    Survey response — day 0, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Adult check-in
  5. 2020-12-21
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  7. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache · Be unable to do your normal daily activities
    Adult check-in
  8. 2020-12-23
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  9. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  12. 2020-12-28
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  13. 2020-12-28
    Call successful
    Participant prefers to complete VAERS report online
  14. 2021-01-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  15. 2021-01-10
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  16. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  17. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-01-18
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  20. 2021-01-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-02
    Survey response — day 21, dose 2
    MedDRA: Abdominal pain, Haemorrhage in pregnancy, Migraine — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Heavy vaginal bleeding, cramping, and migraines during pregnancy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-02
    Report sent to call center — day 21, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-02-19
  24. 2021-04-29
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12020-12-20Pfizer-BioNTech
22021-01-12Pfizer-BioNTech

Call center

4 call center cases

3 successful · 1 unsuccessful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-20

Systemic reaction (other): Dizziness

Release 3 — day 21, dose 2

2021-02-02

Symptoms: Heavy vaginal bleeding, cramping, and migraines during pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain ✓ ✓ ✓
SDHaemorrhage in pregnancy ✓ ✓ ✓
SDMigraine ✓ ✓ ✓
SRODizziness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release